Literature DB >> 9808695

Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC-PK1.

Y Matsuo1, I Yano, T Ito, Y Hashimoto, K Inui.   

Abstract

The transport of quinolone antibacterial drugs by LLC-PK1 monolayers was examined to characterize the renal tubular secretion of these drugs. The transcellular transport of levofloxacin and grepafloxacin from the basolateral to apical side was larger than the transport in the opposite direction. The basal-to-apical transcellular transport and uptake from the basolateral side of levofloxacin showed concentration dependent saturation with an apparent Michaelis constant (Km) of 0.6 and 13 mM, respectively. Various quinolones (1 mM) inhibited the transcellular transport of levofloxacin, and this inhibition was accompanied by a marked increase of cellular accumulation. These results indicated that quinolones interacted more strongly with the transport system on the apical than the basolateral membrane. Neither tetraethylammonium nor cyclosporin A affected the basal-to-apical transcellular transport and accumulation of levofloxacin. The basal-to-apical transcellular transport of levofloxacin was not influenced by either lowering the pH of the apical side or pretreatment of apical membrane with p-chloromercuribenzene sulfonate. These findings indicate that quinolones are specifically transported from the basolateral to apical side by LLC-PK1 monolayers and have higher affinity for the transport system in the apical membrane, a system distinct from H+/organic cation antiport system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808695

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.

Authors:  T Ito; I Yano; S Masuda; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 2.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.

Authors:  Larry A Bauer; Douglas J Black; Jennifer S Lill; Julie Garrison; Vidmantas A Raisys; Thomas M Hooton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Transport of levofloxacin in the OK kidney epithelial cell line: interaction with p-aminohippurate transport.

Authors:  Y Matsuo; I Yano; Y Habu; T Katsura; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

5.  Transepithelial transport of levofloxacin in the isolated perfused rat kidney.

Authors:  T Ito; I Yano; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

6.  Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.

Authors:  Simon Lowes; Nicholas L Simmons
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Effect of rabeprazole on the transport and distribution of levofloxacin in rat stomachs.

Authors:  Junjun Bao; Yongmei Hu; Qiao Mei; Hailun Zhen; Jianming Xu
Journal:  Exp Ther Med       Date:  2014-10-17       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.